Mike Petrovića Alasa, Mike Petrovića Alasa 12-14 Beograd, , RSNowadays science increasingly tends to overcome the limits imposed by the division into physics, chemistry, biology and other traditional disciplines, by creating teams pursuing a multidisciplinary line of research. Such a concept brings together experts from many areas, enabling them to get a multi-faceted insight into a problem and seek solutions through joint work. Vinča Institute of Nuclear Sciences is a place where such an approach to research is enabled by its internal organization and established practices. The research at the Institute covers the following areas: physics, chemistry, biology, power engineering and technology, radiation and environmental protection, accelerator science, and materials science. All of these areas fall within the group of natural and technical sciences. Owing to a multidisciplinary approach, the Institute is capable of responding to the major strategic lines of research defined at the national level: advanced materials and nanoscience, energy engineering and technology, biomedicine and environmental protection. The total number of employees currently fluctuates around 750, out of which over 250 hold a PhD degree.

PO Box 522 Mike Petrovića Alasa 12-14 Belgrade, 11001 SerbiaNowadays science increasingly tends to overcome the limits imposed by the division into physics, chemistry, biology and other traditional disciplines, by creating teams pursuing a multidisciplinary line of research. Such a concept brings together experts from many areas, enabling them to get a multi-faceted insight into a problem and seek solutions through joint work. Vinča Institute of Nuclear Sciences is a place where such an approach to research is enabled by its internal organization and established practices. The research at the Institute covers the following areas: physics, chemistry, biology, power engineering and technology, radiation and environmental protection, accelerator science, and materials science. All of these areas fall within the group of natural and technical sciences. Owing to a multidisciplinary approach, the Institute is capable of responding to the major strategic lines of research defined at the national level: advanced materials and nanoscience, energy engineering and technology, biomedicine and environmental protection. The total number of employees currently fluctuates around 750, out of which over 250 hold a PhD degree.

458 Vojvode Stepe, P.O. Box 1 Beograd, , RSThe Institute of Virology, Vaccines and Sera “Torlak” is a national institution for prevention, treatment and monitoring of infectious diseases. It was founded by the Government of the Republic of Serbia. The Institute “Torlak” is one of the oldest institutions of this kind in the world, with more than 80 years of tradition and experience. The Institute “Torlak” has four national reference laboratories for diagnostics, three of which are certified by the World Health Organization. The Institute carries out scientific research and educational activities in cooperation with the University of Belgrade. The Institute “Torlak” is engaged in: Production of vaccines, sera and other immunobiological and diagnostic preparations Virological, bacteriological and immunological-allergological diagnostics Supplying domestic market with the vaccines from the obligatory immunization program Vaccines storage and distribution - National Vaccine Store Certificate by WHO and UNICEF, 2009

Klęka 1Phytopharm Klęka offers natural extract and raw materials synthesis and analysis services.

Čika Ljubina 16/II 11 000 Belgrade, SerbiaArgint International provides clinical operations, regulatory services, and project management, primarily for eastern european countries.

Studentski trg 1 Beograd, 11000 SerbiaUniversity is an institution which is rightly considered one of the greatest contributions of the peoples of Europe to the world's cultural heritage. The University of Belgrade is a state university. Its main activities in the fields of higher education and scientific research are activities of public interest, and they are carried out in accordance with the legal regulations. The University of Belgrade celebrates September 13 as its day. This is the date when lessons started at the first Higher School, founded by Dositej Obradovic. During the two centuries of its existence the University of Belgrade has served its people, and its former students and teachers have greatly contributed to the development of cultural, scientific, educational, political and economic life of our country. The University of Belgrade is prepared to maintain and enhance its position as the leading institution of higher education in the region by adapting to the challenges of modern times on one hand, and preserving what's worth in its tradition on the other. This is precisely what makes it recognized as a true national brand.

Belgrade SerbiaFidelis Research, a BioIVT Company, is specialised in human biospecimens collection and processing, as well as customised R&D support services. We are a trusted partner of global pharma, biotech and research organisations. Fidelis works with a wide network of over 80 collection sites in Europe and we able to conduct projects tailored to your specific needs for fresh or frozen tissue, bone marrow aspirate, PBMCs, BMMCs, plasma, serum or whole blood samples, FFPEs, matched sets and other custom collections. Our inventory comprises banked solid tumor and hematological malignancies samples. Accelerate your translational research with our bespoke collections and research support solutions.

Klare Cetkin 23/7Parexel provides bioequivalence studies as well as clinical services across Phase I to Phase III of drug development including dose escalation, drug-drug interaction, biomarkers, first-in-man studies, ADME, imaging, and clinical research services.

Bulevar Vojvode Stepe 55/5 Novi Sad, Serbia, 21000 SerbiaBiologicsHub is a highly experienced safety assessment service provider who has an excellent track record in delivering cost-effective projects on time, with high customer satisfaction to our pharmaceutical company partners. We are young, talented scientists from Europe with expertise in research and data management in life sciences.

Karnedzijeva 3/2 Belgrade, Serbia, 11060 SerbiaAt APIS Assay Technologies we combine expertise in Molecular Diagnostic (MDx) Assay Development & Bioinformatics, machine learning and Software Development, with insights from academia and the priorities of global clinicians and health service providers. APIS is a disease and platform-agnostic company that provide bespoke solutions to our client's Assay Development and Bioinformatics & Software Development RFIs. The three main workstreams of our business are: 1. Contract Development of novel Molecular Diagnostic (MDx) Assay Development on medical diagnostic platforms. - Operating under an ISO 13485 QMS and supported by the necessary clinical & compliance teams we have expertise in developing NGS, PCR (RT-qPCR, qPCR, dPCR) and ELISA & ELONA IVD tests. Our onsite microbiology facilities mean we have the capabilities to develop infectious disease diagnostic tests in-house. - APIS offers complete end-to-end contract development solutions covering the entire development pipeline including prototype, pilot and commercial lot manufacturing. This also includes expertise in designing, managing, and documenting global infectious disease Clinical Performance studies under CE-IVDR, UKCA and FDA (510K) requirements. 2. Bioinformatics & Biodata Engineering, ML, AI and Software Development Solutions - Bespoke NGS Bioinformatic Pipeline development in Nextflow & CWL (RNAseq - sc & bulk; WGS; WES; proteomics) - Experts in Single Cell Omics: data processing, analysis & visualisation - Multi-OMICs data analysis platform development - Biomarker Discovery (Biostatistics, ML and AI) - In silico R&D and bespoke visualisation tools - Clinical Diagnostic consensus variant and copy number calling algorithms and reports - in silico retrospective clinical trial simulations utilising RWD/E for novel cohort stratification - Gene & Cell therapy vector integration (VISA) pipeline development (CAR T) 3. Biomarker Industrial Research and Development applied to diagnostic assays, targeting oncology, inflammatory, cardiovascular, infectious disease and inherited disease areas.

458 Vojvode Stepe St. P.O. Box 1 Belgrade, 11152 SerbiaThe Institute of Virology, Vaccines and Sera “Torlak” is a national institution for prevention, treatment and monitoring of infectious diseases. It was founded by the Government of the Republic of Serbia. The Institute “Torlak” is one of the oldest institutions of this kind in the world, with more than 80 years of tradition and experience. The Institute “Torlak” has four national reference laboratories for diagnostics, three of which are certified by the World Health Organization. The Institute carries out scientific research and educational activities in cooperation with the University of Belgrade. The Institute “Torlak” is engaged in: Production of vaccines, sera and other immunobiological and diagnostic preparations Virological, bacteriological and immunological-allergological diagnostics Supplying domestic market with the vaccines from the obligatory immunization program Vaccines storage and distribution - National Vaccine Store Certificate by WHO and UNICEF, 2009